Stoke Therapeutics Inc
STOKHealthcare|Biotechnology|USA
$31.38
-1.47 (-4.47%)
Tangible Book
$6.34
Clinical Trials (7)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06872125 A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | Dravet Syndrome | P3 | Recruiting | 170 | RCT, Double-blind | zorevunersen |
| NCT04740476 An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome | Dravet Syndrome | P2 | Active | 60 | Open-label | zorevunersen (STK-001) |
| NCT05615766 Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation | Spinal Cord Injuries | N/A | Recruiting | 9 | Single-blind | — |
| NCT02179294 A Randomised Controlled Trial of Remifentanil Intravenous Patient Controlled Analgesia (PCA) Versus Intramuscular Pethidine for Pain Relief in Labour | Pain Relief in Labour | P4 | Completed | 401 | RCT, Open-label | Pethidine, Remifentanil |
| NCT00286520 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury | Constipation, Fecal Incontinence | P4 | Completed | 80 | RCT, Open-label | — |
| NCT04442295 An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome | Dravet Syndrome | P1P2 | Completed | 62 | Open-label | STK-001 - Single Ascending Doses, STK-001 - Multiple Ascending Doses |
| NCT00819377 Milrinone Inhaled in Cardiac Surgery | Valvular Stenosis, Valvular Insufficiency | P2 | Completed | 124 | RCT, Double-blind | Milrinone, Normal saline |